Will the Smoldering Myeloma Diagnosis Phase Out?
Published 2022-03-17Download video
Recommendations
-
1:02:06 Interpreting MGUS/Smoldering Myeloma Labs- What To Know and When To Take Action
-
41:10 Multiple Myeloma: What New Patients NEED TO KNOW
-
29:03 Sustainable storytelling, impactful reporting and combatting greenwashing
-
1:10:23 Understanding FISH, Genomics, and Myeloma Genetics
-
44:53 Update in Multiple Myeloma
-
1:05:39 IMWG Conference Series: ASCO & EHA 2023
-
47:00 Common symptoms and presentations of Multiple Myeloma to primary care physicians
-
1:10:32 Newly Diagnosed Multiple Myeloma | Diagnosis, Initial Treatment | ASCT, Maintenance Therapy, Goals
-
1:02:21 GPRC5D and FCRH5 Targeted Therapies in Myeloma
-
07:58 Dr. Mikhael on Challenges, Advances in Multiple Myeloma Treatment
-
07:24 Andy, multiple myeloma survivor
-
11:41 Multiple Myeloma - signs and symptoms, pathophysiology, treatment
-
10:57 Understanding Pre-Myeloma (MGUS)
-
03:15 What is the best diet for myeloma patients to build a strong immune system?
-
18:45 Smoldering Multiple Myeloma: Is it TREATABLE? | What to know about this RARE CANCER
-
49:36 Multiple Myeloma Precursor Conditions | Overview | Therapeutic Intervention
-
1:03:18 Emerging Research in the Smoldering Myeloma Field with Dr. Kazandjian
-
31:15 Multiple Myeloma in 2023: What Patients & Caregivers Need to Know Now!
-
10:20 Understanding Multiple Myeloma (Multiple Myeloma Explained Clearly)
-
53:37 How Do You Afford Your Cancer Drugs? Uncovering Patient Assistance Programs That Can Help
Similar videos
-
03:31 What factors indicate smoldering multiple myeloma (SMM) will progress to active myeloma?
-
01:57 Rationale behind the watch and wait strategy in smoldering myeloma
-
1:03:11 Clinical Trials for Smoldering Myeloma Patients
-
21:10 Smoldering Multiple Myeloma
-
1:02:09 FAQs on Multiple Myeloma: Diagnosis & Prognosis
-
01:38 Daratumumab in the treatment of high-risk MGUS and low-risk smoldering myeloma
-
28:39 Diagnosis and Management of Multiple Myeloma
-
02:12 Dr. Chari on the E3A06 Trial in Smoldering Myeloma
-
56:51 Living Well with Myeloma: MGUS, Smoldering Myeloma, and Newly Diagnosed
-
58:44 Treatments Available for High Risk Smoldering Myeloma Patients
-
22:15 Smoldering myeloma: Who and when to treat?
-
00:41 Improving risk stratification models for patients with MGUS and smoldering myeloma
-
04:41 Genomic characterization of non-progressor smoldering multiple myeloma
-
02:10 Results of iStopMM: prevalence of smoldering myeloma in the general population
-
55:43 FAQs on Newly Diagnosed Multiple Myeloma
-
00:59 History behind how we defined MGUS/Smoldering Myeloma - Part 1 | | Dr. S. Vincent Rajkumar